These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37766097)

  • 1. A Subunit Vaccine Candidate Composed of Mpox Virus A29L, M1R, A35R, and B6R Elicits Robust Immune Response in Mice.
    Yang X; Yang X; Du S; Hu C; Yang X; Wang X; Hu X; Rcheulishvili N; Wang PG; Lin J
    Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge.
    Tang D; Liu X; Lu J; Fan H; Xu X; Sun K; Wang R; Li C; Dan D; Du H; Wang Z; Li X; Yang X
    Front Immunol; 2023; 14():1203410. PubMed ID: 37435062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational development of multicomponent mRNA vaccine candidates against mpox.
    Zhang RR; Wang ZJ; Zhu YL; Tang W; Zhou C; Zhao SQ; Wu M; Ming T; Deng YQ; Chen Q; Jin NY; Ye Q; Li X; Qin CF
    Emerg Microbes Infect; 2023 Dec; 12(1):2192815. PubMed ID: 36947428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three neutralizing mAbs induced by MPXV A29L protein recognizing different epitopes act synergistically against orthopoxvirus.
    Li M; Ren Z; Wang Y; Jiang Y; Yang M; Li D; Chen J; Liang Z; Lin Y; Zeng Z; Xu R; Wang Y; Zhu L; Xiao W; Wu Q; Zhang B; Wan C; Yang Y; Wu B; Peng J; Zhao W; Shen C
    Emerg Microbes Infect; 2023 Dec; 12(2):2223669. PubMed ID: 37288876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus.
    Li E; Guo X; Hong D; Gong Q; Xie W; Li T; Wang J; Chuai X; Chiu S
    Signal Transduct Target Ther; 2023 Sep; 8(1):350. PubMed ID: 37709783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic proteins and potential delivery platforms for mpox virus vaccine development: A rapid review.
    Wang Y; Yang K; Zhou H
    Int J Biol Macromol; 2023 Aug; 245():125515. PubMed ID: 37353117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice.
    Xia H; He YR; Zhan XY; Zha GF
    Antiviral Res; 2023 Aug; 216():105668. PubMed ID: 37429529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus.
    Sang Y; Zhang Z; Liu F; Lu H; Yu C; Sun H; Long J; Cao Y; Mai J; Miao Y; Wang X; Fang J; Wang Y; Huang W; Yang J; Wang S
    Signal Transduct Target Ther; 2023 Apr; 8(1):172. PubMed ID: 37117161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history.
    Xia A; Wang X; He J; Wu W; Jiang W; Xue S; Zhang Q; Gao Y; Han Y; Li Y; Peng X; Xie M; Mayer CT; Liu J; Hua C; Sha Y; Xu W; Huang J; Ying T; Jiang S; Xie Y; Cai Q; Lu L; Silva IT; Yuan Z; Zhang Y; Wang Q
    BMC Biol; 2023 Oct; 21(1):205. PubMed ID: 37784185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge.
    Hou F; Zhang Y; Liu X; Murad YM; Xu J; Yu Z; Hua X; Song Y; Ding J; Huang H; Zhao R; Jia W; Yang X
    Nat Commun; 2023 Sep; 14(1):5925. PubMed ID: 37739969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity.
    Zhang N; Cheng X; Zhu Y; Mo O; Yu H; Zhu L; Zhang J; Kuang L; Gao Y; Cao R; Liang X; Wang H; Li H; Li S; Zhong W; Li X; Li X; Hao P
    Sci China Life Sci; 2023 Oct; 66(10):2329-2341. PubMed ID: 37300753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens.
    Yefet R; Friedel N; Tamir H; Polonsky K; Mor M; Cherry-Mimran L; Taleb E; Hagin D; Sprecher E; Israely T; Freund NT
    iScience; 2023 Feb; 26(2):105957. PubMed ID: 36687315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of multi-epitope vaccines against the monkeypox virus based on envelope proteins using immunoinformatics approaches.
    Tan C; Zhu F; Pan P; Wu A; Li C
    Front Immunol; 2023; 14():1112816. PubMed ID: 36993967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study.
    Cohn H; Bloom N; Cai GY; Clark JJ; Tarke A; Bermúdez-González MC; Altman DR; Lugo LA; Lobo FP; Marquez S; ; Chen JQ; Ren W; Qin L; Yates JL; Hunt DT; Lee WT; Crotty S; Krammer F; Grifoni A; Sette A; Simon V; Coelho CH
    Lancet Infect Dis; 2023 Nov; 23(11):1302-1312. PubMed ID: 37475115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive immune responses to monkeypox virus induced by MVA vaccination in mice.
    Gao F; He C; Liu M; Yuan P; Tian S; Zheng M; Zhang L; Zhou X; Xu F; Luo J; Li X
    Virol J; 2023 Jun; 20(1):126. PubMed ID: 37337226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.
    Lee SJ; Park HJ; Ko HL; Lee JE; Lee HJ; Kim H; Nam JH
    Immun Inflamm Dis; 2020 Jun; 8(2):216-227. PubMed ID: 32167678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection.
    Hu S; Chen H; Ma J; Chen Q; Deng H; Gong F; Huang H; Shi C
    J Appl Microbiol; 2013 Nov; 115(5):1203-11. PubMed ID: 23902541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.
    Hubert M; Guivel-Benhassine F; Bruel T; Porrot F; Planas D; Vanhomwegen J; Wiedemann A; Burrel S; Marot S; Palich R; Monsel G; Diombera H; Gallien S; Lopez-Zaragoza JL; Vindrios W; Taieb F; Fernandes-Pellerin S; Delhaye M; Laude H; Arowas L; Ungeheuer MN; Hocqueloux L; Pourcher V; Prazuck T; Marcelin AG; Lelièvre JD; Batéjat C; Lévy Y; Manuguerra JC; Schwartz O
    Cell Host Microbe; 2023 Jun; 31(6):937-948.e4. PubMed ID: 37196656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Mice from Monkeypoxvirus Lethal Challenge.
    Franceschi V; Parker S; Jacca S; Crump RW; Doronin K; Hembrador E; Pompilio D; Tebaldi G; Estep RD; Wong SW; Buller MR; Donofrio G
    PLoS Negl Trop Dis; 2015 Jun; 9(6):e0003850. PubMed ID: 26086739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mpox vaccine and infection-driven human immune signatures.
    Cohn H; Bloom N; Cai G; Clark J; Tarke A; Bermúdez-González MC; Altman D; Lugo LA; Lobo FP; Marquez S; ; Chen JQ; Ren W; Qin L; Crotty S; Krammer F; Grifoni A; Sette A; Simon V; Coelho CH
    medRxiv; 2023 Mar; ():. PubMed ID: 36945651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.